KCM
JAZZ icon

Kendall Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kendall Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Buy
9,344
+1,040
+13% +$182K 0.36% 71
2025
Q4 		$1.41M Sell
8,304
-150
-2% -$23K 0.3% 88
2025
Q3 		$1.11M Buy
8,454
+225
+3% +$27K 0.25% 101
2025
Q2 		$873K Buy
8,229
+265
+3% +$28.8K 0.23% 110
2025
Q1 		$989K Buy
7,964
+95
+1% +$12.4K 0.29% 91
2024
Q4 		$969K Sell
7,869
-175
-2% -$20.6K 0.28% 91
2024
Q3 		$896K Sell
8,044
-405
-5% -$44.4K 0.28% 98
2024
Q2 		$902K Sell
8,449
-200
-2% -$22K 0.3% 91
2024
Q1 		$1.04M Buy
8,649
+850
+11% +$104K 0.36% 84
2023
Q4 		$959K Buy
7,799
+1,795
+30% +$224K 0.37% 87
2023
Q3 		$777K Buy
6,004
+1,559
+35% +$208K 0.34% 91
2023
Q2 		$551K Buy
4,445
+585
+15% +$78.7K 0.24% 117
2023
Q1 		$565K Buy
3,860
+630
+20% +$93.2K 0.27% 111
2022
Q4 		$515K Hold
3,230
– – 0.26% 112
2022
Q3 		$431K Sell
3,230
-260
-7% -$39.5K 0.25% 115
2022
Q2 		$544K Sell
3,490
-2,010
-37% -$309K 0.3% 103
2022
Q1 		$856K Sell
5,500
-1,995
-27% -$290K 0.41% 77
2021
Q4 		$955K Sell
7,495
-1,115
-13% -$147K 0.45% 76
2021
Q3 		$1.12M Buy
8,610
+410
+5% +$61.9K 0.61% 56
2021
Q2 		$1.46M Buy
8,200
+435
+6% +$75.3K 0.82% 36
2021
Q1 		$1.28M Buy
7,765
+490
+7% +$80.6K 0.79% 42
2020
Q4 		$1.2M Buy
7,275
+125
+2% +$18.6K 0.88% 40
2020
Q3 		$1.02M Buy
7,150
+545
+8% +$67.6K 0.89% 39
2020
Q2 		$729K Buy
6,605
+1,090
+20% +$121K 0.7% 53
2020
Q1 		$550K Sell
5,515
-105
-2% -$13.6K 0.62% 56
2019
Q4 		$839K Buy
5,620
+740
+15% +$101K 0.66% 57
2019
Q3 		$625K Buy
4,880
+2,875
+143% +$385K 0.55% 65
2019
Q2 		$286K Buy
+2,005
New +$269K 0.26% 94

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Kendall Capital Management's JAZZ Position: Q1 2026 in Review

Kendall Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q1 2026, buying an estimated $182K and bringing the position to 9,344 shares worth $1.77M. The position accounts for 0.36% of the portfolio, ranked #71.

Kendall Capital Management first reported a position in JAZZ in Q2 2019 and has held it in 28 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Kendall Capital Management held 9,344 shares of Jazz Pharmaceuticals worth $1.77M as of Q1 2026.
  • Kendall Capital Management bought 1,040 Jazz Pharmaceuticals shares in Q1 2026, an estimated $182K.
  • Jazz Pharmaceuticals made up 0.36% of Kendall Capital Management's portfolio in Q1 2026, its #71 holding.
  • Kendall Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.